Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US $5.4 billion. Supported by more than 41,000 employees globally and 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the ...

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.

Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) …

Sun Pharma is the No. 1 and largest pharmaceutical company in India with over 8% market share in the domestic market (AIOCD AWACS for 12 months ending Sept 2023). The company has been ranked No. 1 with over 12 different classes of doctors (SMSRC Prescription Data).

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over...

Sun Pharmaceutical Industries Ltd., fondly known as Sun Pharma, stands tall as a beacon of innovation and reliability in the pharmaceutical world.

2023年1月23日 · The US Food and Drug Administration (FDA) has written a letter to multinational company Sun Pharmaceuticals accusing it of "significant" manufacturing violations at its plant in Halol, India.

Sun Pharmaceuticals is the largest pharmaceutical company from India and the fifth largest specialty generic company in the world. It has capabilities across dosage forms like injectables, sprays, ointments, creams, liquids, tablets, and capsules.

2025年1月10日 · Recent acquisitions by Sun Pharma. Sun Pharma's most recent acquisition - Libra Merger is a Manufacturer of generic drugs, founded in 2023. Sun Pharma acquired a 100% stake in it in January 2024. Here is the list of all acquisitions by Sun Pharma sorted by the latest acquisition date:

2024年1月18日 · On Thursday, the companies revealed their long-awaited merger, with Sun of Mumbai, India, agreeing to purchase outstanding shares in the Israeli drugmaker for $43 each. The deal nets out to $348...